抗菌剂
化学
药品
细菌
抗生素耐药性
微生物学
抗菌肽
抗感染药
抗菌药物
共聚物
抗生素
抗药性
生物膜
抗菌剂
药物发现
活性成分
抗菌活性
生物活性
生物
作者
Shoshana C. Williams,Gabriel Greenstein,Xinyu Liu,Alessio Fragasso,Noah Eckman,Alexander N. Prossnitz,Changxin Dong,Anna Makar-Limanov,Christine Jacobs‐Wagner,Lynette Cegelski,Hector Lopez Hernandez,Eric Andrew Appel
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2025-11-07
标识
DOI:10.1101/2025.11.07.687243
摘要
ABSTRACT Antimicrobial resistance poses an urgent and increasing threat to global health. The development of new antimicrobials is crucial. Synthetic copolymers are attractive as a potential solution, because they can be produced at scale and designed to mimic antimicrobial peptides and act as broad-spectrum antimicrobials capable of evading resistance mechanisms. This work leverages a cross-molecular machine learning pipeline, trained on antimicrobial peptides, to develop potent antimicrobial polymers to combat Escherichia coli , which were then synthesized and validated experimentally. One candidate copolymer was further characterized and shown to permeabilize the bacterial membrane, which is associated with decreased resistance. Furthermore, this copolymer demonstrated remarkable synergy in eradicating biofilm-associated E. coli when combined with a first-line clinical drug regimen, reducing the amount needed to eradicate bacteria in biofilms by three orders of magnitude. These results demonstrate promise for potentiating antibacterial activity of currently available antibiotics, treating serious and complicated infections, and combatting antimicrobial resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI